Crossignal Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
505 Coast Blvd S Ste 406, La Jolla, Cali...Phone Number
(858) 203-3183Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Crossignal Therapeutics
Crossignal Therapeutics is focused on developing innovative small molecule anti-cancer immunotherapies that target tumor metabolic factors. The company is committed to discovering and designing drug candidates that inhibit pathways involved in cancer immune escape. Their pipeline includes clinical stage programs such as CT3001 and CT3021, as well as early-stage discovery programs. Crossignal aims to provide solutions for challenging GPCR targets in the field of immuno-oncology.Explore more
Popular SearchesCrossignal Therapeutics IncSIC Code 87,873NAICS Code 54,541Show more
Crossignal Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Crossignal Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Crossignal Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Crossignal Therapeutics
Earning: See what the market has to say on Crossignal Therapeutics recently announced quarterly report
Product Launch: Get notified when Crossignal Therapeutics launches new products
Crossignal Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Crossignal Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Crossignal Therapeutics has new funding data
Check out if Crossignal Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Crossignal Therapeutics
Compare insights from companies similar to Crossignal Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Crossignal Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Crossignal Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Crossignal Therapeutics.
Crossignal Therapeutics Tech Stack
A closer look at the technologies used by Crossignal Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crossignal Therapeutics
Sign Up For FreeTo access detailed company insights
Crossignal Therapeutics is focused on developing innovative small molecule anti-cancer immunotherapies that target tumor metabolic factors. The company is committed to discovering and designing drug candidates that inhibit pathways involved in cancer immune escape. Their pipeline includes clinical stage programs such as CT3001 and CT3021, as well a... Read More
